Main variables;Branches of activity;Total
No. of companies carrying out R&D in Biotechnology;Total Companies;1.299
No. of companies carrying out R&D in Biotechnology;Services;774
No. of companies carrying out R&D in Biotechnology;Industry and Construction;424
No. of companies carrying out R&D in Biotechnology;Agriculture;101
%Companies according to biotechnology used: Genetic code;Total Companies;30,8
%Companies according to biotechnology used: Genetic code;Services;39,6
%Companies according to biotechnology used: Genetic code;Industry and Construction;16,8
%Companies according to biotechnology used: Genetic code;Agriculture;22,4
%Companies according to biotechnology used: Functional units;Total Companies;38,4
%Companies according to biotechnology used: Functional units;Services;42,6
%Companies according to biotechnology used: Functional units;Industry and Construction;34,2
%Companies according to biotechnology used: Functional units;Agriculture;23,7
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Total Companies;21,5
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Services;26
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Industry and Construction;14,3
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Agriculture;17,4
%Companies according to biotechnology used: Bioprocesses;Total Companies;50,8
%Companies according to biotechnology used: Bioprocesses;Services;40
%Companies according to biotechnology used: Bioprocesses;Industry and Construction;74,7
%Companies according to biotechnology used: Bioprocesses;Agriculture;32,7
%Companies according to biotechnology used: Sub-cellular organisms;Total Companies;8,5
%Companies according to biotechnology used: Sub-cellular organisms;Services;11,6
%Companies according to biotechnology used: Sub-cellular organisms;Industry and Construction;4,3
%Companies according to biotechnology used: Sub-cellular organisms;Agriculture;2,1
%Companies according to biotechnology used: Bio-computing;Total Companies;24
%Companies according to biotechnology used: Bio-computing;Services;34,5
%Companies according to biotechnology used: Bio-computing;Industry and Construction;9,1
%Companies according to biotechnology used: Bio-computing;Agriculture;6
%Companies according to biotechnology used: Nanobiotechnology;Total Companies;12,1
%Companies according to biotechnology used: Nanobiotechnology;Services;16,8
%Companies according to biotechnology used: Nanobiotechnology;Industry and Construction;6,1
%Companies according to biotechnology used: Nanobiotechnology;Agriculture;1
%Companies according to biotechnology used: Other;Total Companies;16,9
%Companies according to biotechnology used: Other;Services;19
%Companies according to biotechnology used: Other;Industry and Construction;8,1
%Companies according to biotechnology used: Other;Agriculture;37,6
Companies in which biotechnology activities are: Main and/or exclusive;Total Companies;559
Companies in which biotechnology activities are: Main and/or exclusive;Services;442
Companies in which biotechnology activities are: Main and/or exclusive;Industry and Construction;97
Companies in which biotechnology activities are: Main and/or exclusive;Agriculture;21
Companies in which biotechnology activities are: A secondary line of business;Total Companies;230
Companies in which biotechnology activities are: A secondary line of business;Services;129
Companies in which biotechnology activities are: A secondary line of business;Industry and Construction;83
Companies in which biotechnology activities are: A secondary line of business;Agriculture;18
Companies in which biotechnology activities are: A tool necessary for production;Total Companies;510
Companies in which biotechnology activities are: A tool necessary for production;Services;203
Companies in which biotechnology activities are: A tool necessary for production;Industry and Construction;244
Companies in which biotechnology activities are: A tool necessary for production;Agriculture;63
%Company by field(s) of ultimate application of biotechnology use: Human Health;Total Companies;45,5
%Company by field(s) of ultimate application of biotechnology use: Human Health;Services;61,2
%Company by field(s) of ultimate application of biotechnology use: Human Health;Industry and Construction;26,2
%Company by field(s) of ultimate application of biotechnology use: Human Health;Agriculture;6,2
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Total Companies;15,5
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Services;16,9
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Industry and Construction;11
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Agriculture;23,7
%Company by field(s) of ultimate application of biotechnology use: Food products;Total Companies;32,3
%Company by field(s) of ultimate application of biotechnology use: Food products;Services;21,7
%Company by field(s) of ultimate application of biotechnology use: Food products;Industry and Construction;51,5
%Company by field(s) of ultimate application of biotechnology use: Food products;Agriculture;32,9
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Total Companies;23,8
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Services;20,4
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Industry and Construction;21,3
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Agriculture;59,8
%Company by field(s) of ultimate application of biotechnology use: Environment;Total Companies;15,6
%Company by field(s) of ultimate application of biotechnology use: Environment;Services;16,3
%Company by field(s) of ultimate application of biotechnology use: Environment;Industry and Construction;14,9
%Company by field(s) of ultimate application of biotechnology use: Environment;Agriculture;13,4
%Company by field(s) of ultimate application of biotechnology use: Industry;Total Companies;13,7
%Company by field(s) of ultimate application of biotechnology use: Industry;Services;14,6
%Company by field(s) of ultimate application of biotechnology use: Industry;Industry and Construction;14,5
%Company by field(s) of ultimate application of biotechnology use: Industry;Agriculture;4,1
Personnel in R&D in biotechnology (no. of persons);Total Companies;15.750
Personnel in R&D in biotechnology (no. of persons);Services;9.680
Personnel in R&D in biotechnology (no. of persons);Industry and Construction;5.035
Personnel in R&D in biotechnology (no. of persons);Agriculture;1.036
Personnel in R&D in biotechnology (no. of persons): Research personnel;Total Companies;8.379
Personnel in R&D in biotechnology (no. of persons): Research personnel;Services;5.975
Personnel in R&D in biotechnology (no. of persons): Research personnel;Industry and Construction;2.144
Personnel in R&D in biotechnology (no. of persons): Research personnel;Agriculture;261
Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel;Total Companies;7.371
Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel;Services;3.704
Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel;Industry and Construction;2.891
Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel;Agriculture;775
Personnel in R&D in biotechnology (no. of persons). Women;Total Companies;8.711
Personnel in R&D in biotechnology (no. of persons). Women;Services;5.499
Personnel in R&D in biotechnology (no. of persons). Women;Industry and Construction;2.773
Personnel in R&D in biotechnology (no. of persons). Women;Agriculture;438
Personnel in R&D in biotechnology (no. of persons). Women: Research personnel;Total Companies;4.510
Personnel in R&D in biotechnology (no. of persons). Women: Research personnel;Services;3.287
Personnel in R&D in biotechnology (no. of persons). Women: Research personnel;Industry and Construction;1.119
Personnel in R&D in biotechnology (no. of persons). Women: Research personnel;Agriculture;104
Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel;Total Companies;4.200
Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel;Services;2.212
Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel;Industry and Construction;1.655
Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel;Agriculture;333
Personnel in R&D in biotechnology (FTE);Total Companies;11.528,6
Personnel in R&D in biotechnology (FTE);Services;7.260,7
Personnel in R&D in biotechnology (FTE);Industry and Construction;3.657,9
Personnel in R&D in biotechnology (FTE);Agriculture;610,1
Personnel in R&D in biotechnology (FTE): Research personnel;Total Companies;6.342,7
Personnel in R&D in biotechnology (FTE): Research personnel;Services;4.531,8
Personnel in R&D in biotechnology (FTE): Research personnel;Industry and Construction;1.631,6
Personnel in R&D in biotechnology (FTE): Research personnel;Agriculture;179,3
Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel;Total Companies;5.185,9
Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel;Services;2.728,8
Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel;Industry and Construction;2.026,3
Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel;Agriculture;430,8
Personnel in R&D in biotechnology (FTE). Women;Total Companies;6.539,7
Personnel in R&D in biotechnology (FTE). Women;Services;4.129,4
Personnel in R&D in biotechnology (FTE). Women;Industry and Construction;2.140,4
Personnel in R&D in biotechnology (FTE). Women;Agriculture;270
Personnel in R&D in biotechnology (FTE). Women: Research personnel;Total Companies;3.455,7
Personnel in R&D in biotechnology (FTE). Women: Research personnel;Services;2.476,3
Personnel in R&D in biotechnology (FTE). Women: Research personnel;Industry and Construction;905,7
Personnel in R&D in biotechnology (FTE). Women: Research personnel;Agriculture;73,7
Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel;Total Companies;3.084
Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel;Services;1.653
Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel;Industry and Construction;1.234,7
Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel;Agriculture;196,3
Internal expenditure on R&D (thousands of euros);Total Companies;1.038.582
Internal expenditure on R&D (thousands of euros);Services;614.188
Internal expenditure on R&D (thousands of euros);Industry and Construction;382.984
Internal expenditure on R&D (thousands of euros);Agriculture;41.410
1) By nature of the expense: Current expenses;Total Companies;940.091
1) By nature of the expense: Current expenses;Services;558.041
1) By nature of the expense: Current expenses;Industry and Construction;344.917
1) By nature of the expense: Current expenses;Agriculture;37.132
1.1) Remuneration to research personnel;Total Companies;321.570
1.1) Remuneration to research personnel;Services;213.833
1.1) Remuneration to research personnel;Industry and Construction;98.160
1.1) Remuneration to research personnel;Agriculture;9.577
1.2) Remuneration to technicians and auxiliary personnel;Total Companies;194.836
1.2) Remuneration to technicians and auxiliary personnel;Services;94.194
1.2) Remuneration to technicians and auxiliary personnel;Industry and Construction;87.790
1.2) Remuneration to technicians and auxiliary personnel;Agriculture;12.851
1.3) Other current expenses;Total Companies;423.685
1.3) Other current expenses;Services;250.013
1.3) Other current expenses;Industry and Construction;158.967
1.3) Other current expenses;Agriculture;14.704
2) By nature of the expense: Capital expenses;Total Companies;98.492
2) By nature of the expense: Capital expenses;Services;56.147
2) By nature of the expense: Capital expenses;Industry and Construction;38.067
2) By nature of the expense: Capital expenses;Agriculture;4.278
2.1) Land and buildings;Total Companies;10.199
2.1) Land and buildings;Services;6.083
2.1) Land and buildings;Industry and Construction;2.952
2.1) Land and buildings;Agriculture;1.165
2.2) Equipment and instruments;Total Companies;72.584
2.2) Equipment and instruments;Services;38.296
2.2) Equipment and instruments;Industry and Construction;32.431
2.2) Equipment and instruments;Agriculture;1.858
2.3) Acquisition of specific R&D software;Total Companies;5.721
2.3) Acquisition of specific R&D software;Services;3.732
2.3) Acquisition of specific R&D software;Industry and Construction;1.850
2.3) Acquisition of specific R&D software;Agriculture;138
2.4) Otros productos de propiedad intelectual específicos para I+D;Total Companies;9.987
2.4) Otros productos de propiedad intelectual específicos para I+D;Services;8.037
2.4) Otros productos de propiedad intelectual específicos para I+D;Industry and Construction;833
2.4) Otros productos de propiedad intelectual específicos para I+D;Agriculture;1.117
1.1) By origin of the funds: Own funds;Total Companies;711.488
1.1) By origin of the funds: Own funds;Services;359.197
1.1) By origin of the funds: Own funds;Industry and Construction;316.843
1.1) By origin of the funds: Own funds;Agriculture;35.448
1.2) By origin of the funds: From companies;Total Companies;121.738
1.2) By origin of the funds: From companies;Services;107.930
1.2) By origin of the funds: From companies;Industry and Construction;9.208
1.2) By origin of the funds: From companies;Agriculture;4.600
1.3) By origin of the funds: Public Administration funds;Total Companies;107.477
1.3) By origin of the funds: Public Administration funds;Services;91.272
1.3) By origin of the funds: Public Administration funds;Industry and Construction;14.871
1.3) By origin of the funds: Public Administration funds;Agriculture;1.334
1.4) By origin of the funds: From Universities;Total Companies;192
1.4) By origin of the funds: From Universities;Services;182
1.4) By origin of the funds: From Universities;Industry and Construction;11
1.4) By origin of the funds: From Universities;Agriculture;0
1.5) By origin of the funds: From non profit private institutions;Total Companies;10.756
1.5) By origin of the funds: From non profit private institutions;Services;10.585
1.5) By origin of the funds: From non profit private institutions;Industry and Construction;171
1.5) By origin of the funds: From non profit private institutions;Agriculture;0
1.6) By origin of the funds: Foreign funds;Total Companies;86.931
1.6) By origin of the funds: Foreign funds;Services;45.023
1.6) By origin of the funds: Foreign funds;Industry and Construction;41.880
1.6) By origin of the funds: Foreign funds;Agriculture;27
Purchase of R&D services in biotechnology (thousands of euros);Total Companies;145.557
Purchase of R&D services in biotechnology (thousands of euros);Services;74.421
Purchase of R&D services in biotechnology (thousands of euros);Industry and Construction;70.048
Purchase of R&D services in biotechnology (thousands of euros);Agriculture;1.088
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Total Companies;95.915
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Services;52.406
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Industry and Construction;42.780
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Agriculture;729
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Total Companies;49.642
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Services;22.015
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Industry and Construction;27.268
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Agriculture;359
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Total Companies;40,2
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Services;48,8
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Industry and Construction;28
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Agriculture;25,5
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Total Companies;13,2
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Services;13
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Industry and Construction;14,2
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Agriculture;10,2
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Total Companies;19
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Services;20,3
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Industry and Construction;17,3
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Agriculture;16,3
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Total Companies;11,5
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Services;11,5
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Industry and Construction;11,4
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Agriculture;12,1
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Total Companies;15,9
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Services;18
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Industry and Construction;12,5
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Agriculture;13,4
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels;Total Companies;17
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels;Services;20,3
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels;Industry and Construction;11,3
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels;Agriculture;15,3
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Total Companies;16,4
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Services;16,5
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Industry and Construction;16,5
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Agriculture;16,1
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Total Companies;40,5
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Services;42,9
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Industry and Construction;37,1
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Agriculture;36,7
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;Total Companies;55
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;Services;58,7
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;Industry and Construction;48,7
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;Agriculture;52,9
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Total Companies;21,9
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Services;22,3
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Industry and Construction;20,1
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Agriculture;26,3
% Companies with income of an international origin related to biotechnological activities;Total Companies;23,5
% Companies with income of an international origin related to biotechnological activities;Services;26,2
% Companies with income of an international origin related to biotechnological activities;Industry and Construction;22,4
% Companies with income of an international origin related to biotechnological activities;Agriculture;7,2
% Turnover representing income of an international origin related to biotechnological activities;Total Companies;1,9
% Turnover representing income of an international origin related to biotechnological activities;Services;4,1
% Turnover representing income of an international origin related to biotechnological activities;Industry and Construction;1,6
% Turnover representing income of an international origin related to biotechnological activities;Agriculture;2,2
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU;Total Companies;61,6
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU;Services;62,4
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU;Industry and Construction;61,2
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU;Agriculture;68,3
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries;Total Companies;38,4
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries;Services;37,6
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries;Industry and Construction;38,8
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries;Agriculture;31,7
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Total Companies;87,6
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Services;83,2
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Industry and Construction;89,1
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Agriculture;85
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Total Companies;10,9
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Services;12,2
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Industry and Construction;10,8
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Agriculture;0
% Income of an international origin related with activities according to the classification: Operating source abroad;Total Companies;1,1
% Income of an international origin related with activities according to the classification: Operating source abroad;Services;4,3
% Income of an international origin related with activities according to the classification: Operating source abroad;Industry and Construction;0,1
% Income of an international origin related with activities according to the classification: Operating source abroad;Agriculture;0
% Income of an international origin related with activities according to the classification: Other;Total Companies;0,4
% Income of an international origin related with activities according to the classification: Other;Services;0,3
% Income of an international origin related with activities according to the classification: Other;Industry and Construction;0
% Income of an international origin related with activities according to the classification: Other;Agriculture;15